BioFeyn

BioFeyn's mission is to create better feed for better fish. In the simplest sense, we are improving what farmed fish eat. We are optimizing ingredients so fish can get more of what they naturally get in the ocean. We are doing so through a system of biocompatible and biodegradable encapsulations, which both protects marine ingredients and amplifies their effect. Trace amounts of marine ingredients are surrounded by a shell of other naturally-derived compounds. This ensures better digestion, absorption, bioavailability, and delivery to target tissues in the animals to help them grow and remain healthy.

France

About Us
CEO: Timothy Bouley, MD, MSc

Trained as a medical doctor and environmental scientist, Timothy has previously worked at the US National Academy of Sciences, the World Health Organization, the University of California, San Francisco, and the World Bank. There, he led programs on environment and health, including aquaculture, agriculture, and oceans. He holds degrees in biology, bioethics, geography, and medicine from Tufts, Harvard, Oxford, and Duke.

CSO: Marie-Christine Imbert, PhD

Marie-Christine is a molecular biologist and specialist in sustainable finance. Previously, she founded an addiction treatment application company, SoberLife, a sustainable hot-cocoa pop-up, and worked as an advisor to Global Changemakers, a non-profit that helps foster elements of social entrepreneurship in youth. She worked for a decade in sustainable investment and private equity at LGT Capital Partners. Marie has PhD from Cambridge University and separately trained as financial analyst.

Problem we are solving
Our technology enables the use of more sustainable marine ingredients by bringing down costs and enhancing existing technologies already on the market. Improved efficiencies that result from the use of BioFeyn technology also reduce pollution and improve overall marine health.

Sustainable Impact on Blue Ecconomy
"Our technology is tiny - we are building technology to operate at the nano to micro level. Because of this, we can rapidly operate at scale, without the typical infrastructure constraints associated with rapid-growth businesses. We only need 1kg of BioFeyn product to integrate into 1 metric ton of feed. That’s a ratio of 1/1000.

A further advantage has to do with our team and technology’s close association with the world of human biomedicine and biotechnology. Billions of dollars have already been invested in this technology in some form or another for human medicine. We are bringing our understanding of and connections from this field to aquaculture, where we can have rapid and quantifiable impact in a field with far lower regulatory barriers and time horizons to revenues. "

Financial Needs3000000